The Director of the program is Olivier Hermine. The new governance of the Labex GR-Ex include 5 bureaus
The Executive Committee (EC) is composed of 3 members:
- Olivier Hermine (Chair)
- Caroline Le Van Kim
- Laurent Gouya
Role: As the decision-making body, the EC define and supervise the general strategy of the GR-Ex project and oversee the budget. EC meetings will be held twice a year, each March with the Scientific Advisory Board and each September. Meetings can also be called upon by special request of any of the EC or Scientific Committee members in order to respond to a clearly defined need.
The Scientific Committee (SC) is comprised of 11 elected GR-Ex members. Their respective expertise include:
- Erythropoiesis: Lydie da Costa and Ivavn Cruz Moura
- Iron metabolism: Carole Peyssonnaux and Zoubida Karim
- Sickle cell disease: Jacques Elion
- Malaria: Benoît Gamain
- Blood transfusion: Thierry Peyrard
- Genetics: Paul-Henri Roméo
- Clinical studies: Pierre Buffet
- Basic science: Catherine Etchebest and Naomi Taylor
Role: The SC will advise on the GR-Ex scientific policy, organize at least one scientific workshop per topic/year, write scientific reports and evaluate projects received from the internal call for proposals.
The Education Committee (EdC) is comprised of 3 elected GR-Ex members:
- Anaïs Merckx
- Stéphane Egée
- Wassim El Nemer
Role: The EdC will develop both training courses and lab workshops, eventually elaborate and/or sponsor Master programs and create a Massive Open Online Courses on erythropoiesis and iron metabolism.
The Valorization Committee (VC) is comprised of two members:
- Olivier Hermine
- Joël Veiga
Role: The VC develop collaborations with other scientific institutions, both in France and abroad. It will collaborate with the French government organization focused on promoting industrial relations (SATT Idf Innov) to develop partnerships with the private sector and promote core facility sharing amongst GR-Ex partners.
The Scientific Advisory Board (SAB), currently chaired by Mohandas Narla, is internationally renowned and is comprised of 5 members with expertise in diverse aspects of the red cell field:
- Mohandas Narla, New York Blood Center, USA
- Catherine Lacombe, Paris Descartes University, Cochin Institute, France
- Mario Cazzola, University of Pavia, Italy
- Patrick G. Gallagher, Yale University, USA
- Russell E. Ware, Cincinnati Children’s Hospital Medical Center, USA
Role: The SAB spearhead the global review of the consortium’s activities, advise on the integration of new research partners, and evaluate projects from the internal call for proposals.